比较脊柱融合联合减压与单纯减压治疗退变性腰椎滑脱的成本-结果分析
本研究基于加拿大脊柱结局与研究网络前瞻性多中心观察队列数据,从有限社会视角对332例腰椎退变性滑脱患者进行成本-结果分析,其中248例(75%)接受融合联合减压、84例(25%)接受单纯减压。两年时两组ODI、SF-12与QALY评分在未调整和调整模型中均无统计学显著差异,但融合联合减压第一年费用更高(CAD$13,534 vs $6,540),翻修率亦更高(9% vs 4%)。作者认为对多数患者而言融合联合减压在经济上似乎并不合理,未来需确定哪些基线特征可支持其增加的费用。
要点
- 两年时融合联合减压与单纯减压的ODI、SF-12、QALY评分在未调整和调整模型中均无统计学显著差异。
- 第一年融合联合减压费用CAD$13,534,高于单纯减压的$6,540。
- 融合联合减压翻修率9%,高于单纯减压的4%。
核心结论
- 融合联合减压比单纯减压费用更高;尽管两组基线PROMs不同,术后PROMs相似。
- 作者认为对多数腰椎退变性滑脱患者而言,融合联合减压在经济上似乎并不合理,未来需进一步研究以确定哪些基线特征可支持增加的费用。
研究设计与样本
- 采用加拿大脊柱结局与研究网络(Canadian Spine Outcomes and Research Network)数据库的前瞻性、多中心、观察性队列数据,从有限社会视角进行成本-结果分析。
- 患者自付费用由日记估算,机构成本由入组量最大的站点病例成本数据估算;未评估成本-效果,而是独立呈现每种治疗的结果与费用。
- 健康结局指标为Oswestry功能障碍指数(ODI)、基于EuroQol五维问卷(EQ-5D-5L)的质量调整生命年(QALYs)和12项简表健康调查问卷(SF-12)。
- 采用增强逆概率治疗加权控制混杂变量对结局的潜在影响。
- 共纳入332例患者:248例(75%)接受融合联合减压,84例(25%)接受单纯减压,时间范围为2015年8月至2020年2月。
主要发现
- 两年时ODI、SF-12和QALY评分在未调整模型与调整模型中,融合联合减压组与单纯减压组之间均无统计学显著差异,尽管融合联合减压组基线患者报告结局指标(PROMs)显著更差。
- 第一年融合联合减压费用为CAD$13,534,单纯减压为$6,540。
- 总体翻修率融合联合减压组为9%,单纯减压组为4%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to compare outcomes of combined fusion and decompression with decompression alone in patients with lumbar degenerative sponylolisthesis. Traditional cost-effectiveness analysis was avoided due to the prospective nature of the two groups of patients. METHODS: A cost-consequence analysis using prospective, multicentred, observational cohort data from the Canadian Spine Outcomes and Research Network database was performed from a limited societal perspective. The patients' out-of-pocket expenses were estimated from diaries. Institutional costs were estimated from case costing data from the site with greatest enrolment. Cost-effectiveness was not assessed. Instead, the outcomes and costs associated with each form of treatment are presented independently. The Oswestry Disability Index (ODI), quality-adjusted life years (QALYs) from EuroQol five-dimension questionnaire (EQ-5D-5L), and the 12-Item Short-Form Health Survey questionnaire (SF-12) were recorded as the health outcomes. The potential effects of confounding variables on outcomes were controlled using augmented inverse probability of treatment weighting. RESULTS: There were a total of 332 patients: 248 (75%) had a fusion and decompression and 84 (25%) underwent decompression alone, between August 2015 and February 2020. There were no statistically significant differences in ODI, SF-12, and QALY scores in either the unadjusted or the adjusted models at two years between the two groups, although the baseline patient-reported outcome measures (PROMs) were significantly worse for those who underwent fusion and decompression. Fusion and decompression (CAD$13,534) was more costly compared with decompression alone ($6,540) at year one. The overall revision rate was increased in those who underwent fusion and decompression (9%) compared with decompression alone (4%). CONCLUSION: Fusion and decompression was more costly than decompression alone. The PROMs were similar postoperatively in the two groups despite differences at baseline. Thus, fusion and decompression for most patients with lumbar degenerative sponylolisthesis would seem not to be justified financially, and future work is required to determine the baseline characteristics of the patients which would justify the increased costs.
引用
- Hillier T, Rampersaud YR, Koto P, et al. A cost-consequence analysis comparing spinal fusion and decompression with decompression alone in the treatment of degenerative spondylolisthesis. Bone Joint J. 2025. PMID: 41319684. doi:10.1302/0301-620X.107B12.BJJ-2025-0219.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。